Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Pre Market
Current status date:
2022-02-24
Original market date: See footnote 1
Product name:
AMPICILLIN SODIUM FOR INJECTION, BP
Description:
SINGLE DOSE VIAL
DIN:
02445123
Product Monograph/Veterinary Labelling:
Date:
2019-03-05
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
MYLAN PHARMACEUTICALS ULC
85 Advance Road
Etobicoke
Ontario
Canada
M8Z 2S6
Class:
Human
Dosage form(s):
Powder For Solution
Route(s) of administration:
Intravenous , Intramuscular
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
Anatomical Therapeutic Chemical (ATC): See footnote 4
Active ingredient group (AIG) number:See footnote5
0105872005
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| AMPICILLIN (AMPICILLIN SODIUM) | 2000 MG / VIAL |